OncoCyte Corporation
NASDAQ:OCX
3.08 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 9.432 | 19.993 | 35.605 | 7.143 | 22.072 | 8.034 | 7.6 | 10.174 | 7.996 | 0.257 | 0.101 |
| Short Term Investments
| 0 | 0.433 | 0.904 | 0.675 | 0.379 | 0.428 | 0.76 | 2.237 | 2.541 | 3.28 | 4.63 |
| Cash and Short Term Investments
| 9.432 | 20.426 | 36.509 | 7.818 | 22.451 | 8.462 | 8.36 | 12.411 | 10.537 | 3.537 | 4.731 |
| Net Receivables
| 0.484 | 2.012 | 1.437 | 0.203 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 2.121 | 0.304 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 0.782 | 0.977 | 1.197 | 1.205 | 0.505 | 0.18 | 0.168 | 0.285 | 0.388 | 0.114 | 0.12 |
| Total Current Assets
| 10.698 | 25.536 | 39.143 | 9.226 | 22.956 | 8.642 | 8.528 | 12.696 | 10.925 | 3.651 | 4.851 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 5.436 | 10.851 | 8.527 | 6.524 | 3.728 | 0.614 | 0.822 | 0.688 | 0.576 | 0.118 | 0.148 |
| Goodwill
| 0 | 0 | 18.684 | 9.187 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 56.595 | 61.633 | 91.245 | 15.009 | 0 | 0 | 0.746 | 0.988 | 1.23 | 1.472 | 1.714 |
| Goodwill and Intangible Assets
| 56.595 | 61.633 | 109.929 | 24.196 | 0 | 0 | 0.746 | 0.988 | 1.23 | 1.472 | 1.714 |
| Long Term Investments
| 1.7 | 1.7 | 1.7 | 13.417 | 10.964 | 0 | 0 | 0 | 0 | 0 | -1.574 |
| Tax Assets
| -0 | -1.7 | -1.7 | 0.118 | 0 | 0 | 0 | 0 | 0 | 1.115 | 1.574 |
| Other Non-Current Assets
| 0.463 | 2.071 | 1.964 | 1.938 | 2.211 | 0.262 | 0.12 | 0.075 | 0 | 0 | 1.574 |
| Total Non-Current Assets
| 64.194 | 74.555 | 120.42 | 46.193 | 16.903 | 0.876 | 1.688 | 1.751 | 1.806 | 2.705 | 3.436 |
| Total Assets
| 74.892 | 100.091 | 159.563 | 55.419 | 39.859 | 9.518 | 10.216 | 14.447 | 12.731 | 6.356 | 8.287 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 0.953 | 1.253 | 2.447 | 0.432 | 0.469 | 0.166 | 0.175 | 0.422 | 0.285 | 0.144 | 0.103 |
| Short Term Debt
| 0.665 | 0.815 | 2.132 | 2.812 | 1.355 | 1.185 | 1.138 | 0.202 | 0.847 | 5.889 | 2.963 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 5.152 | 0 | 0 | 0 | 0 | -0.847 | 0 | 0 |
| Other Current Liabilities
| 5.576 | 10.038 | 9.541 | 0.6 | 2.616 | 4.21 | 3.141 | 3.651 | 2.029 | 1.397 | 1.606 |
| Total Current Liabilities
| 7.194 | 12.106 | 14.12 | 8.996 | 4.44 | 5.561 | 4.454 | 4.275 | 2.314 | 7.43 | 4.672 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 2.204 | 2.729 | 3.545 | 5.82 | 4.581 | 0.534 | 1.359 | 0.31 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 39.9 | 50.964 | 76.681 | 7.12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 42.104 | 53.693 | 80.226 | 12.94 | 4.581 | 0.534 | 1.359 | 0.31 | 0 | 0 | 0 |
| Total Liabilities
| 49.298 | 65.799 | 94.346 | 21.936 | 9.021 | 6.095 | 5.813 | 4.585 | 2.314 | 7.43 | 4.672 |
| Equity: | |||||||||||
| Preferred Stock
| 5.126 | 5.302 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 310.295 | 294.929 | 252.954 | 157.16 | 124.583 | 74.742 | 59.968 | 45.818 | 34.901 | 15.147 | 15.398 |
| Retained Earnings
| -289.876 | -260.676 | -187.774 | -123.677 | -93.745 | -71.319 | -54.677 | -35.302 | -24.134 | -15.399 | -10.413 |
| Accumulated Other Comprehensive Income/Loss
| 0.049 | 0.039 | 0.037 | 0 | 0 | 0 | -0.888 | -0.654 | -0.35 | -0.822 | -1.37 |
| Other Total Stockholders Equity
| 0 | -5.302 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
| Total Shareholders Equity
| 25.594 | 34.292 | 65.217 | 33.483 | 30.838 | 3.423 | 4.403 | 9.862 | 10.417 | -1.074 | 3.615 |
| Total Equity
| 25.594 | 34.292 | 65.217 | 33.483 | 30.838 | 3.423 | 4.403 | 9.862 | 10.417 | -1.074 | 3.615 |
| Total Liabilities & Shareholders Equity
| 74.892 | 100.091 | 159.563 | 55.419 | 39.859 | 9.518 | 10.216 | 14.447 | 12.731 | 6.356 | 8.287 |